Total Funding
4
Total FundingSeries A raised
Growth Score
pts
Heat Score
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
395633
DVS Sciences develops bioanalytical solutions for use in biomarker discovery, biological research and clinical applications.
Scott Tanner: President , CEO & Co-Founder, Board MembersPast Role: MDS, Principal Scientist- Mary-Kay Lippert: VP Operations, CanadaPast Role: SCIEX, Director, Business Process Improvement, Manufacturing; Senior Manager, Manufacturing
About the Company
DVS Sciences, Inc. manufactures and has global distribution of novel bioanalytical solutions for use in biomarker discovery, biological research and possible clinical applications. The patented multi-parameter solution comprises a high-throughput mass cytometer for quantitative individual cell analysis, CyTOF®, and a suite of MAXPAR® reagents,
which include stable-isotope-tagged antibodies. The CyTOF — MAXPAR system overcomes the limitations of conventional flow cytometry, simplifies sample preparation and simultaneously identifies up to 100 biomarkers with high resolution and wide dynamic range. CyTOF systems are installed in leading laboratories across the U.S., Canada and Asia.
Women Founded
